You are here
NANOTHERAPEUTICS, INC.
UEI: GC2RFAZK8G64
# of Employees: 70
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine
Amount: $2,992,765.00DESCRIPTION provided by applicant Noroviruses are a group of enteropathogenic viruses belonging to the taxonomic family Caliciviridae which causes approximately of epidemic non bacterial outbreaks of ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine
Amount: $578,711.00DESCRIPTION (provided by applicant): Noroviruses are a group of enteropathogenic viruses belonging to the taxonomic family Caliciviridae, which causes approximately 90% of epidemic non-bacterial outbr ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health -
Development of A Synthetic Typhoid Fever Vaccine as A Substitution of Vi Vaccine
Amount: $595,945.00DESCRIPTION (provided by applicant) Typhoid fever is a major cause of morbidity worldwide with an estimated incidence of 16 to 33 million infections and 500,000 to 600,000 deaths annually. It is caus ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
ORAL BUPRENORPHINE NANOPARTICLE FORMULATION
Amount: $116,660.00Not Available
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Technologies to Defeat Improvised Explosive Devices (IED’s)
Amount: $940,875.00The overall goal of this Phase II project is to develop the Nanobreath® detection system for proximity detection of explosives at 50 meters, and specifically detection of peroxide improvised explosiv ...
SBIRPhase II2006Department of Defense Navy -
Antimicrobial Bone Graft Substitute
Amount: $69,938.00In this Phase I SBIR project, Nanotherapeutics proposes to utilize its proprietary particle delivery systems to develop an injectable bone paste formulation incorporating an anti-microbial (PHMB) as a ...
SBIRPhase I2005Department of Defense Army -
ORAL BUPRENORPHINE NANOPARTICLE FORMULATION
Amount: $775,506.00N/A
SBIRPhase II2005Department of Health and Human Services National Institutes of Health -
Oral Therapy using Anti-Oxidants for Alzheimer's Disease
Amount: $100,816.00DESCRIPTION (provided by applicant): Nanotherapeutics proposes to evaluate oral taurine therapy for Alzheimer's disease (AD). AD, the most common form of dementia among older people, affects over 4 mi ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
ORAL BUPRENORPHINE NANOPARTICLE FORMULATION
Amount: $98,838.00N/A
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Technologies to Defeat Improvised Explosive Devices (IED's)
Amount: $99,745.00In this Phase I SBIR Proposal, Nanotherapeutics, Inc. proposes to demonstrate the improved proximity detection of hexamethylene triperoxidediamine (HMTD) and triacetone triperoxide (TATP) explosives u ...
SBIRPhase I2004Department of Defense Navy
